The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is a new state-of-the-art R&D satellite of the Tata Memorial Centre (TMC). It has the mandate to function as a national centre for treatment, education and research in cancer.

TMC is an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India. It is registered under the Societies Registration Act (1860) and the Bombay Public Trust Act (1950). It is governed by a Governing Council chaired by the Chairman, Atomic Energy Commission, Government of India.

ACTREC comprises of 2 arms – a basic research arm constituted by the erstwhile Cancer Research Institute (CRI) which has shifted from the Parel Campus to the new location in August 2002, and a Clinical Research Centre (CRC) which will begin functioning by the end of 2003. The latter comprises of a 50 bed research hospital which is fully equipped with state-of-the-art diagnostic & therapeutic facilities.

Research investigations at CRI currently focus on molecular mechanisms responsible for causation of major human cancers relevant to India. It is envisaged that in the future, ACTREC will play a greater role in drug development and emerging therapies for treatment and prevention of cancer.